Silicon Valley Bank joins Babraham’s Accelerate pantheon
Cambridge-based international law firm Taylor Vinters and technology focused banking group Silicon Valley Bank have joined the organisations backing Accelerate@Babraham’s inaugural programme.
Babraham Research Campus’ life-science accelerator has gained traction in a short space of time. Designed to support the earliest stages of new life-science ventures, via the provision of easy-access laboratory and office space together with supporting programmes of business, science, finance and entrepreneurial mentoring, Accelerate@Babraham’s inaugural programme starts later this month.
Six companies are enrolled on the programme, five of which won access along with a raft of other benefits, including £20K non-dilutive funding, via a pitching competition which took place over the summer.
As Business Weekly announced first, the super six were Antiverse Ltd, Kalium Diagnostics, Oppilotech Ltd, Qkine Ltd and VisusNano Ltd. SNPr, a spin-out of the Babraham Institute, which is developing a platform technology that enables the linking of genomic variants (SNPs) in non-coding genomic regions to their target genes, will also join the programme.
Taylor Vinters and Silicon Valley Bank will support the startups via a series of 1-2-1 clinics and workshops. The programme begins on September 20t and will run through until mid-December.
In addition to Taylor Vinters and Silicon Valley Bank, Accelerate@Babraham is supported by five key Strategic Partners – AstraZeneca, Eli Lilly, MedImmune, One Nucleus and RxCelerate – all of which are committed to providing hands-on support via mentoring and entrepreneurial guidance, as well as being actively involved in the ongoing strategic development of the initiative.
Patrick Farrant, senior partner at Taylor Vinters said: “Taylor Vinters has enjoyed a close partnership with the Babraham Research Campus for over a decade.
“We are thrilled to be involved with Accelerate@Babraham, supporting the development of innovative science concepts and the creation of new companies – something which is a core focus of the firm.”
Nooman Haque, managing director for Life Sciences & Healthcare at Silicon Valley Bank added: “Silicon Valley Bank is committed to helping next-generation entrepreneurs navigate the roadmap of building a startup.
“Accelerate@Babraham, as part of the wider Babraham Research Campus provides a superb starting point for fledging life science companies within the Cambridge Cluster and as such is an initiative we are very proud to support.”